COMING SOON

PROGRAM OVERVIEW

This activity immerses learners in interactive, case-based discussions led by multidisciplinary experts to address clinical challenges in the evolving continuum of high-risk cutaneous squamous cell carcinoma (cSCC). Experts will overview dynamic approaches to risk stratification, the role of adjuvant immunotherapy, and emerging strategies for neoadjuvant treatment, while highlighting the importance of multidisciplinary care and proactive management of immunotherapy-related adverse events. To enrich the learning experience, participants will also have access to an AI virtual assistant that provides on-demand resources and reflection points to facilitate learning and retention of key concepts.

SPEAKING FACULTY

TARGET AUDIENCE

This activity is designed to meet the educational needs of medical oncologists, radiation oncologists, surgeons (Mohs and surgical oncologists), dermatologists, advanced practice professionals (including nurse practitioners and physician assistants), and nurses who are involved in the treatment and care of patients with high-risk cSCC.

LEARNING OBJECTIVES

Upon completion of this enduring activity, attendees will have improved ability to:

• Identify patients with high-risk cSCC, through risk stratification criteria and staging
• Assess the clinical data for emerging neoadjuvant immunotherapies for the treatment of cSCC and how to utilize neoadjuvant approaches in clinical practice
• Evaluate the clinical data for current and emerging adjuvant immunotherapies to inform their integration into clinical practice for cSCC treatment
• Determine the importance of multidisciplinary care to improve disease and patient outcomes for individuals living with cSCC
• Apply interprofessional strategies to manage AEs in patients undergoing immunotherapy for cSCC

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtual activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.

ACCME INNOVATION PARTNER

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

ACCME INNOVATION PARTNER DISCLAIMER

Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
• Shpetim Karandrea, PhD, Medical Director for Med Learning Group has nothing to disclose.
• Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
• Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
• Nicolas Applyrs Jr, D.O., M.S., M.P.H., has nothing to disclose.
• La Donna Lue Winston, MSN, APRN, AGACNP-BC, SCRN, RN, has nothing to disclose.
• Marissa Mays-Verman, Program Director for Med Learning Group, has nothing to disclose.
• Melanie Grau, Program Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This enduring activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: February 02, 2026
EXPIRATION DATE: February 02, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.